viko

©EBA

EBA 2019 Helsinki

CUTISS AG is present with a booth at the EBA 2019 in Helsinki. Further information about the congress, also for the upcoming events of the EBA can be found under “Learn more”

csem final

CSEM article on Innosuisse Grant

Swiss researchers want to develop the first-ever automated machine to bioengineer personalised skin grafts for therapy. The denovoCast project, a collaboration between life science start-up Cutiss AG and CSEM, has been awarded a grant of more than CHF 800’000 by Innosuisse.

Interview with Daniela Marino on CNN Money Switzerland

Switzerland is perfect for Startups, but… Switzerland boasts some of the best skills in the world, according to Daniela Marino. The Cutiss CEO says Switzerland is also the “perfect place” to be an entrepreneur. So what’s the catch? When it comes to money, Swiss investors aren’t as willing to take risks as their American counterparts.

Interview mit Daniela Marino auf CNN Money Switzerland.

©CUTISS

Interview with Daniela Marino on Moneycab.com

“The B round will need to provide 30-40 million CHF to support the market access.”

by Patrick Gunti

Moneycab.com: Ms. Marino, Cutiss has developed a revolutionary method to produce human skin in the lab. How did that happen?
In 2001 the Tissue Biology Reseach Unit, a research lab of the Department of Surgery of the University Children’s hospital in Zurich started working on skin bio-engineering to solve an unmet clinical need mostly connected to burns. Unfortunately, standard of care to treat large, deep burns is scarce and ineffective leading very often to highly debilitating, disfiguring scarring. Via personalized skin tissue bio-engineering one could permanently treat large wound surfaces and minimize the scarring.

Forbes article about CUTISS “La peau sur mesure”

Article in French only.

Start-up suisse créée en 2017 et spécialisée dans la biotechnologie, CUTISS AG est une jeune entreprise adossée à l’Université de Zürich. Son application ? La peau ! Spécialisée dans la reconstitution de peau sur-mesure, Cutiss travaille main dans la main avec des hôpitaux européens, Suisses, Hollandais et Anglais, et travaille déjà à son futur : démocratiser la fabrication de peau pour les grands blessés et pour toutes les autres personnes ayant besoin d’une greffe de peau.

EU final

CUTISS receives SME Instrument Grant

CUTISS AG receives SME Instrument Grant for 2.5 Million Euros to automate.

Read more about this on startupticker.ch –

Cutiss, SamanTree Medical and RqMicro have been selected for the SME Instrument. The startups will be supported in the Phase 2 of the SMI Instrument, with up to €2.5 million in funding.

Scroll to Top

Newsletter

Would you like to contact us as a journalist?

This website uses cookies to ensure you get the best experience on our website.